Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Gryska David W, Consejero. Director active across 6 companies, notably Seagen Inc.. Aggregated, 20 filings have been logged. Split: 2 buys · 1 sell. Total volume traded: €986k. History available since 14 May 2021. The latest transaction was filed on 5 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gryska David W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
GRYSKA DAVID W is Administrateur. He appears in 19 filings in total, and in the sampled recent filings between 2016-01-08 and 2026-06-15, the reported amounts are EUR 35,875 in buys and EUR 11,427,886 in sells, with the transaction nature mainly shown as Attribution. His listed companies are Seagen Inc., Mind Medicine (MindMed) Inc., Aerie Pharmaceuticals INC, Definium Therapeutics, Inc., Forte Biosciences, Inc., and INCYTE CORP.